Cytotherapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.5 | Q1 | 79.6% | 1.249 | Q1 | 88.9% |
| 2024 | 3.2 | Q2 | 71.7% | 1.007 | Q1 | 84.4% |
| 2023 | 3.7 | Q2 | 65.6% | 1.084 | Q1 | 87.4% |
| 2022 | 4.5 | Q2 | 68.2% | 1.186 | Q1 | 89.8% |
| 2021 | 6.2 | Q2 | 79.1% | 1.004 | Q1 | 86.5% |
| 2020 | — | — | 1.192 | Q1 | 88.8% | |
| 2019 | — | — | 1.233 | Q1 | 89.7% | |
| 2018 | — | — | 1.287 | Q1 | 89.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1465-3249
ISSN
1477-2566
country
UScoverage
1999-2026